head to head comparisons of sglt2 inhibitors
Published 2 weeks ago • 182 plays • Length 7:56Download video MP4
Download video MP3
Similar videos
-
5:22
ada 2021 – grade: head-to-head comparison of metformin add-ons for type 2 diabetes | deborah wexler
-
24:16
diabetes medications - sglt2 inhibitors - canagliflozin and metformin (invokamet)
-
12:28
when should we use sglt2 inhibitors?
-
7:43
choosing sglt2 inhibitors vs glp-1 receptor agonists
-
3:35
sglt-2 inhibitors, explained: how they work, their benefits and risks
-
6:14
the daily debate - sglt-2 inhibitors and t1d
-
8:15
sglt2 inhibitors and heart failure
-
6:57
how does dapagliflozin work? understanding sglt2 inhibitors.
-
5:31
sglt-2 inhibitors - dapagliflozin, empagliflozin, canagliflozin & ertugliflozin
-
32:00
role of sglt2 inhibitors in ckd
-
4:41
cv risk in t2d: role of sglt2 inhibition
-
59:24
cwmgr: the expanding multiverse of sglti in & beyond diabetes
-
4:05
mohamed eid, md, mph, mha: emprise data at aha 2019
-
0:54
ask the expert – how do you choose the right medical treatment for diabetes?
-
46:01
ckd e-learning - sglt-2 inhibitors and ckd - 05.19.21
-
5:05
sglt2 inhibitors: cv outcomes data in type 2 diabetes
-
27:44
are there alternative mechanisms to explain sglt2i beneficial cveffects in some patients?
-
10:17
acc 2018: sglt-2 inhibitors versus other glucose lowering drugs